Peritoneal Dialysis during the COVID-19 Pandemic Is an Effective Treatment in Developing Countries: A Report from Mexico
Blood Purification · 2023
DOI: 10.1159/000534198 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Blood Purification, 2023. Verfasst von Alberto Villa-Torres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Centro Medico ISSEMYM, Toluca, Mexico. Hauptthemen laut MEDLINE: COVID-19, Peritoneal Dialysis, Acute Kidney Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
During the height of the coronavirus disease-19 (COVID-19) pandemic, some renal replacement therapy (RRT) modalities were insufficient, forcing medical centers to diversify the RRT modalities offered. In this study, we reported the outcomes of chronic peritoneal dialysis (PD) patients and acute PD in critically ill patients during COVID-19 pandemic in a tertiary care medical center in Mexico.
Methods
This descriptive, longitudinal, observational, retrospective study included 47 adult patients with atypical pneumonia in a tertiary care medical center in Mexico during the first and second waves of the COVID-19 pandemic. Chronic PD patients and PD incident patients due to acute kidney injury (AKI) were included.
Results
Forty-seven patients were studied (29 chronic PD patients and 18 incident PD patients due to AKI); median age was 59 (48–68) years; 63.8% were men. The ultrafiltrate volume per day was 815 (596.1–1,193.2) mL. Overall mortality was 61.7%, 55.2% in chronic PD patients, and 72.2% in PD incident patients due to AKI. A higher Sequential Organ Failure Assessment (SOFA) score, the need for mechanical ventilation at admission, and the requirement for vasopressors were predictors for mortality (p < 0.01).
Conclusion
In low- and lower-middle-income countries, PD was a valid alternative for RRT during the COVID-19 pandemic. In AKI patients, PD can correct hyperkalemia, acidosis, uremia, and volume overload; however, there was higher mortality in PD incident patients due to AKI. The main risk factors for mortality were a high SOFA score at admission, the need for invasive mechanical ventilation, and the requirement for vasopressors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Centro Medico ISSEMYM, Toluca, Mexico.
- Department of Nephrology, Hospital Juarez de Mexico, Mexico City, Mexico.
- Department of Internal Medicine, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico.
Zitieren
APA
Villa-Torres, A., Vásquez-Jiménez, E., Velazquez-Silva, R. I., Herrera-Arellano, L., Acosta-García, N., Aleman-Quimbiulco, D., Duarte-Pérez, R., Carmona Bautista, C. A., & Rodríguez-Chagolla, J. M. (2023). Peritoneal Dialysis during the COVID-19 Pandemic Is an Effective Treatment in Developing Countries: A Report from Mexico. Blood Purification. https://doi.org/10.1159/000534198
Vancouver
Villa-Torres A, Vásquez-Jiménez E, Velazquez-Silva RI, Herrera-Arellano L, Acosta-García N, Aleman-Quimbiulco D, et al. Peritoneal Dialysis during the COVID-19 Pandemic Is an Effective Treatment in Developing Countries: A Report from Mexico. Blood Purification. 2023. doi:10.1159/000534198
BibTeX
@article{VillaTorres2023,
author = {Villa-Torres, Alberto and Vásquez-Jiménez, Enzo and Velazquez-Silva, Ricardo Iván and Herrera-Arellano, Leticia and Acosta-García, Nayeli and Aleman-Quimbiulco, Dolores and Duarte-Pérez, Ricardo and Carmona Bautista, Carlos A and Rodríguez-Chagolla, José Manuel},
title = {Peritoneal Dialysis during the COVID-19 Pandemic Is an Effective Treatment in Developing Countries: A Report from Mexico},
journal = {Blood Purification},
year = {2023},
doi = {10.1159/000534198}
}
EUVIMED